JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
Clinical trial NCT06079983 · RECRUITING
Trial details
- NCT number
- NCT06079983
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-04-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.